Coles N Anthony
- SEC CIK
- 0001197018
No open-market purchases or sales filed in the past year.
Current role at each company
- REGN Regeneron Pharmaceuticals, Inc.Directoras of Jan 6, 2026
- CERE Cerevel Therapeutics Holdings, Inc.Directoras of Aug 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Coles N Anthony as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CERE Cerevel Therapeutics Holdings, Inc.
Director20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 (view filing) | Dec 9 | 4 days | Coles N AnthonyCEO and Chairperson | SSale | −50.0K | $26.67 | −$1.33M | −94.9%2.70K after | 2 lots |
| Jan 6, 2023 (view filing) | Jan 5 | 1 day | Coles N AnthonyCEO and Chairperson | SSale | −50.0K | $29.94 | −$1.50M | −94.9%2.70K after | 2 lots |
| Feb 8, 2023 (view filing) | Feb 7 | 1 day | Coles N AnthonyCEO and Chairperson | SSale | −50.0K | $33.12 | −$1.66M | −94.9%2.70K after | 2 lots |
| Mar 6, 2023 (view filing) | Mar 2-3 | 4 days | Coles N AnthonyCEO and Chairperson | SSale | −50.0K | $27.11 | −$1.36M | −94.9%2.70K after | 2 lots |
| Apr 13, 2023 (view filing) | Apr 11 | 2 days | Coles N AnthonyCEO and Chairperson | SSale | −50.0K | $25.06 | −$1.25M | −94.9%2.70K after | 10b5-1 |
| May 8, 2023 (view filing) | May 4 | 4 days | Coles N AnthonyCEO and Chairperson | SSale | −50.0K | $31.47 | −$1.57M | −94.9%2.70K after | 3 lots10b5-1 |
| Jun 5, 2023 (view filing) | Jun 1 | 4 days | Coles N AnthonyCEO and Chairperson | SSale | −50.0K | $32.60 | −$1.63M | −94.9%2.70K after | 10b5-1 |
| Jul 13, 2023 (view filing) | Jul 11 | 2 days | Coles N AnthonyDirector | SSale | −50.0K | $30.03 | −$1.50M | −94.9%2.70K after | 10b5-1 |
| Sep 8, 2023 (view filing) | Sep 7 | 1 day | Coles N AnthonyDirector | SSale | −50.0K | $24.07 | −$1.20M | −94.9%2.70K after | |
| Nov 6, 2023 (view filing) | Nov 2-3 | 4 days | Coles N AnthonyDirector | SSale | −100.0K | $25.34 | −$2.53M | −97.4%2.70K after | 2 lots |
REGN Regeneron Pharmaceuticals, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 (view filing) | Aug 13 | 3 days | Coles N AnthonyDirector | SSale | −2.00K | $625.00 | −$1.25M | −68.9%902 after | |
| Aug 19, 2021 (view filing) | Aug 17-18 | 2 days | Coles N AnthonyDirector | SSale | −6.00K | $650.00 | −$3.90M | −86.9%902 after | 2 lots |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Coles N AnthonyDirector | SSale | −11.9K | $658.98 | −$7.87M | −93.0%902 after | 13 lots |
| Sep 8, 2022 (view filing) | Sep 6 | 2 days | Coles N AnthonyDirector | SSale | −6.00K | $581.28 | −$3.49M | −84.6%1.09K after | 9 lots |
| Dec 30, 2022 (view filing) | Dec 28 | 2 days | Coles N AnthonyDirector | SSale | −5.76K | $714.11 | −$4.11M | −84.0%1.09K after | 8 lots |